Back to company

PHARMA-SKAN ApS: Financial statements 2016

CVR: 16275247

PHARMA-SKAN ApS (CVR 16275247) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 13,236,971 and a net result of DKK 9,967,894 compared with DKK 11,200,711 the year before. That is a decrease of 11.7% compared with the year before. Equity amounted to DKK 15,287,828. The solvency ratio was 36.8%. The company had 11 employees in the financial year.

Gross Profit
13,236,971 kr.
Profit/Loss
9,967,894 kr.
Equity
15,287,828 kr.
Total Assets
41,574,935 kr.
Employees
11

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-13.2 mio.10 mio.15.3 mio.11
2015-15 mio.11.2 mio.15.3 mio.10
2014-11.5 mio.8.3 mio.14.1 mio.8
2013-11.4 mio.8.2 mio.15.8 mio.9
2012-11.6 mio.8.4 mio.17.6 mio.10

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMA-SKAN ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

PHARMA-SKAN ApS: The 2015 annual report is outMay 20, 2016

PHARMA-SKAN ApS has published its annual report for 2015. Gross profit came to DKK 14,994,922, and the net result was DKK 11,200,711.

About PHARMA-SKAN ApS

PHARMA-SKAN ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS KBUS 38 NR. 2587. The management consists of Ib Gunnar Christensen and Line Wulff. The company is owned by BESULA ApS. The company has 16 employees. In 2025, the company reported a gross profit of DKK 12,339,941 and a net result of DKK 7,875,190 compared with DKK 11,288,304 the year before. Equity amounted to DKK 8,543,005.